Praxis Launches Patient Recruitment Program for Women's Health Medical Research Studies
Posted on: Wednesday, 14 May 2008, 12:00 CDT
Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a rapidly growing biotechnology company for three national medical research studies. The studies explore a possible treatment for an important women's health issue.
After an in-depth feasibility analysis of all protocols, Praxis created one umbrella recruitment program uniquely targeted to the patient population required for each protocol. Praxis is managing the enrollment program and providing a variety of recruitment and retention tactics including website development, advertising, patient education materials, direct marketing, and centralized recruitment center management, delivering pre-qualified study candidates to the appropriate research sites. Patients will participate for up to five years in this comprehensive program.
"These studies are significant to us in a number of ways," said David L. Fox, President and CEO of Praxis. "This program cultivates a new relationship with an exciting biotechnology company and enhances our expertise in the area of women's health -- an area we have significant experience in. These studies will also benefit from PraxisDirect 2.0, our recently-enhanced study management technology that offers our sponsor the unique convenience of logging in to one place to access enrollment metrics from all three study protocols in the program at a glance. We've been very excited to have the opportunity to strategically create this umbrella program for 3 different protocols, maximizing our sponsor's return on investment."
Praxis Communications, Inc., headquartered in Brentwood, Tenn., provides the pharmaceutical and biotechnology industries with a wide range of services for patient recruitment and retention for clinical trials in North America and abroad, including feasibility analysis, patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207 or visit www.GoPraxis.com.
Source: Business Wire
Related Articles
- Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies With REOLYSIN(R)
- Patient-Centric Healthcare Study Reveals Key Insights for Pharmaceutical Marketers
- Semafore and Multiple Myeloma Research Consortium (MMRC) Dose First Patient in Phase I Study of Targeted PI3 Kinase (PI3K) Inhibitor
- Obecure Recruits First Patient in Obesity Study
- St. Paul Heart Clinic Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- St. Francis Hospital Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Newark Beth Israel Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- California Pacific Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- U. Enlists Patients in Clinical Study Linked to Fatal Lung Disease
- Agilix Study in Nature Biotechnology Validates First Universal Microarray RNA Expression Analysis System
 |
 |
User Comments (0)
RSS Feeds